BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 26652047)

  • 1. FMR6 may play a role in the pathogenesis of fragile X-associated premature ovarian insufficiency.
    Elizur SE; Dratviman-Storobinsky O; Derech-Haim S; Lebovitz O; Dor J; Orvieto R; Cohen Y
    Gynecol Endocrinol; 2016; 32(4):334-7. PubMed ID: 26652047
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Granulosa cell and oocyte mitochondrial abnormalities in a mouse model of fragile X primary ovarian insufficiency.
    Conca Dioguardi C; Uslu B; Haynes M; Kurus M; Gul M; Miao DQ; De Santis L; Ferrari M; Bellone S; Santin A; Giulivi C; Hoffman G; Usdin K; Johnson J
    Mol Hum Reprod; 2016 Jun; 22(6):384-96. PubMed ID: 26965313
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of FMR4, FMR5 and FMR6 Expression Levels as Non-Invasive Biomarkers for the Diagnosis of Fragile X-Associated Primary Ovarian Insufficiency (FXPOI).
    Alvarez-Mora MI; Agusti I; Wijngaard R; Martinez-Barrios E; Barcos T; Borras A; Peralta S; Guimera M; Goday A; Manau D; Rodriguez-Revenga L
    J Clin Med; 2022 Apr; 11(8):. PubMed ID: 35456280
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pathophysiology Mechanisms in Fragile-X Primary Ovarian Insufficiency.
    Elizur SE; Friedman Gohas M; Dratviman-Storobinsky O; Cohen Y
    Methods Mol Biol; 2019; 1942():165-171. PubMed ID: 30900184
    [TBL] [Abstract][Full Text] [Related]  

  • 5. FMRpolyG accumulates in FMR1 premutation granulosa cells.
    Friedman-Gohas M; Elizur SE; Dratviman-Storobinsky O; Aizer A; Haas J; Raanani H; Orvieto R; Cohen Y
    J Ovarian Res; 2020 Feb; 13(1):22. PubMed ID: 32101156
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Elevated levels of FMR1 mRNA in granulosa cells are associated with low ovarian reserve in FMR1 premutation carriers.
    Elizur SE; Lebovitz O; Derech-Haim S; Dratviman-Storobinsky O; Feldman B; Dor J; Orvieto R; Cohen Y
    PLoS One; 2014; 9(8):e105121. PubMed ID: 25153074
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reduced RNA expression of the FMR1 gene in women with low (CGGn<26) repeats.
    Wang Q; Barad DH; Darmon SK; Kushnir VA; Wu YG; Lazzaroni-Tealdi E; Zhang L; Albertini DF; Gleicher N
    PLoS One; 2018; 13(12):e0209309. PubMed ID: 30576349
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The ovarian response in fragile X patients and premutation carriers undergoing IVF-PGD: reappraisal.
    Avraham S; Almog B; Reches A; Zakar L; Malcov M; Sokolov A; Alpern S; Azem F
    Hum Reprod; 2017 Jul; 32(7):1508-1511. PubMed ID: 28472405
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evidence for a fragile X messenger ribonucleoprotein 1 (FMR1) mRNA gain-of-function toxicity mechanism contributing to the pathogenesis of fragile X-associated premature ovarian insufficiency.
    Rosario R; Stewart HL; Choudhury NR; Michlewski G; Charlet-Berguerand N; Anderson RA
    FASEB J; 2022 Nov; 36(11):e22612. PubMed ID: 36250920
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diminished ovarian reserve is not observed in infertility patients with high normal CGG repeats on the fragile X mental retardation 1 (FMR1) gene.
    Schufreider A; McQueen DB; Lee SM; Allon R; Uhler ML; Davie J; Feinberg EC
    Hum Reprod; 2015 Nov; 30(11):2686-92. PubMed ID: 26345686
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Correlation of FMR4 expression levels to ovarian reserve markers in FMR1 premutation carriers.
    Agusti I; Alvarez-Mora MI; Wijngaard R; Borras A; Barcos T; Peralta S; Guimera M; Goday A; Manau D; Rodriguez-Revenga L
    J Ovarian Res; 2024 May; 17(1):103. PubMed ID: 38760837
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The significance of fragile X mental retardation gene 1 CGG repeat sizes in the normal and intermediate range in women with primary ovarian insufficiency.
    Voorhuis M; Onland-Moret NC; Janse F; Ploos van Amstel HK; Goverde AJ; Lambalk CB; Laven JS; van der Schouw YT; Broekmans FJ; Fauser BC;
    Hum Reprod; 2014 Jul; 29(7):1585-93. PubMed ID: 24812319
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long Noncoding RNA Can Be a Probable Mechanism and a Novel Target for Diagnosis and Therapy in Fragile X Syndrome.
    Huang G; Zhu H; Wu S; Cui M; Xu T
    Front Genet; 2019; 10():446. PubMed ID: 31191598
    [TBL] [Abstract][Full Text] [Related]  

  • 14. FMR1 expression in human granulosa cells increases with exon 1 CGG repeat length depending on ovarian reserve.
    Rehnitz J; Alcoba DD; Brum IS; Dietrich JE; Youness B; Hinderhofer K; Messmer B; Freis A; Strowitzki T; Germeyer A
    Reprod Biol Endocrinol; 2018 Jul; 16(1):65. PubMed ID: 29981579
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of CGG repeat number on ovarian response among fragile X premutation carriers undergoing preimplantation genetic diagnosis.
    Bibi G; Malcov M; Yuval Y; Reches A; Ben-Yosef D; Almog B; Amit A; Azem F
    Fertil Steril; 2010 Aug; 94(3):869-74. PubMed ID: 19481741
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dysregulation of anti-Mullerian hormone expression levels in mural granulosa cells of FMR1 premutation carriers.
    Friedman-Gohas M; Orvieto R; Michaeli A; Aizer A; Kirshenbaum M; Cohen Y
    Sci Rep; 2021 Jul; 11(1):14139. PubMed ID: 34238973
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Deregulation of key signaling pathways involved in oocyte maturation in FMR1 premutation carriers with Fragile X-associated primary ovarian insufficiency.
    Alvarez-Mora MI; Rodriguez-Revenga L; Madrigal I; Garcia-Garcia F; Duran M; Dopazo J; Estivill X; Milà M
    Gene; 2015 Oct; 571(1):52-7. PubMed ID: 26095811
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reproductive health of adolescent girls who carry the FMR1 premutation: expected phenotype based on current knowledge of fragile x-associated primary ovarian insufficiency.
    De Caro JJ; Dominguez C; Sherman SL
    Ann N Y Acad Sci; 2008; 1135():99-111. PubMed ID: 18574214
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Refining the risk for fragile X-associated primary ovarian insufficiency (FXPOI) by FMR1 CGG repeat size.
    Allen EG; Charen K; Hipp HS; Shubeck L; Amin A; He W; Nolin SL; Glicksman A; Tortora N; McKinnon B; Shelly KE; Sherman SL
    Genet Med; 2021 Sep; 23(9):1648-1655. PubMed ID: 33927378
    [TBL] [Abstract][Full Text] [Related]  

  • 20. FMR1 and the continuum of primary ovarian insufficiency.
    Sullivan SD; Welt C; Sherman S
    Semin Reprod Med; 2011 Jul; 29(4):299-307. PubMed ID: 21969264
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.